James P. Allison
Impact in
- Immunology top 0.01%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 312
- Immunotherapy and Immune Responses 183
- Immune Cell Function and Interaction 166
- T-cell and B-cell Immunology 151
- Oncology 233
- Cancer Immunotherapy and Biomarkers 180
- CAR-T cell therapy research 81
- Co-authors
- Padmanee Sharma (94 shared papers)Matthew F. Krummel (9 shared papers)Dana R. Leach (3 shared papers)Cynthia A. Chambers (18 shared papers)Jedd D. Wolchok (34 shared papers)Spencer C. Wei (5 shared papers)Karl S. Peggs (12 shared papers)Colm R. Duffy (8 shared papers)
- Journals
- The Journal of Immunology (56 papers)Journal of Clinical Oncology (42 papers)Proceedings of the National Academy of Sciences (40 papers)The Journal of Experimental Medicine (24 papers)Cancer Immunology Research (16 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
James P. Allison
473 papers receiving 71.6k citations
James P. Allison's Hit Papers
Peers
Comparison fields: 5 of 190
- Immunology 46.5k
- Oncology 35.9k
- Biological Psychiatry 603
- Cancer Research 3.1k
- Radiology, Nuclear Medicine and Imaging 4.4k
Countries citing papers authored by James P. Allison
This map shows the geographic impact of James P. Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Allison more than expected).
Fields of papers citing papers by James P. Allison
This network shows the impact of papers produced by James P. Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Allison. The network helps show where James P. Allison may publish in the future.
Co-authors
The 25 scholars most cited alongside James P. Allison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 486 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The future of immune checkpoint therapy Hit paper breakdown → | 2015 | 3647 |
| 2 | Restoring function in exhausted CD8 T cells during chronic viral infection Hit paper breakdown → | 2005 | 3138 |
| 3 | Enhancement of Antitumor Immunity by CTLA-4 Blockade Hit paper breakdown → | 1996 | 2951 |
| 4 | Fundamental Mechanisms of Immune Checkpoint Blockade Therapy Hit paper breakdown → | 2018 | 2253 |
| 5 | CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Hit paper breakdown → | 1995 | 1748 |
| 6 | Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential Hit paper breakdown → | 2015 | 1745 |
| 7 | PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors Hit paper breakdown → | 2010 | 1474 |
| 8 | CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones Hit paper breakdown → | 1992 | 1359 |
| 9 | Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Hit paper breakdown → | 2003 | 1235 |
| 10 | Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma Hit paper breakdown → | 2013 | 1110 |
| 11 | The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research Hit paper breakdown → | 2009 | 1059 |
| 12 | Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells Hit paper breakdown → | 1993 | 977 |
| 13 | Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade Hit paper breakdown → | 2017 | 951 |
| 14 | Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting Hit paper breakdown → | 2012 | 942 |
| 15 | Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy Hit paper breakdown → | 2016 | 937 |
| 16 | Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses Hit paper breakdown → | 2001 | 834 |
| 17 | Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation Hit paper breakdown → | 1999 | 824 |
| 18 | CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy Hit paper breakdown → | 2001 | 805 |
| 19 | Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer Hit paper breakdown → | 2005 | 792 |
| 20 | Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Hit paper breakdown → | 2003 | 780 |
About James P. Allison
James P. Allison is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 486 papers that have together received 73.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (183 papers), Cancer Immunotherapy and Biomarkers (180 papers), Immune Cell Function and Interaction (166 papers), T-cell and B-cell Immunology (151 papers), CAR-T cell therapy research (81 papers), Monoclonal and Polyclonal Antibodies Research (37 papers), Behavioral and Psychological Studies (27 papers) and Diabetes and associated disorders (23 papers). The work is most often cited by research in Immunology (46.5k citations), Oncology (35.9k citations), Biological Psychiatry (603 citations), Cancer Research (3.1k citations) and Radiology, Nuclear Medicine and Imaging (4.4k citations). James P. Allison has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Padmanee Sharma, Matthew F. Krummel, Dana R. Leach, Cynthia A. Chambers, Jedd D. Wolchok, Spencer C. Wei, Karl S. Peggs, Colm R. Duffy, Jackson G. Egen and Wendy L. Havran. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
You can learn more about the impact of James P. Allison by visiting their Pantheon page.